Versant Capital Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.4K Sell
186
-40
-18% -$4.82K ﹤0.01% 2006
2026
Q2
$30.1K Buy
+226
New +$25.6K ﹤0.01% 1715

Other funds holding ABVX

Versant Capital Management's ABVX Position: Q3 2026 in Review

Versant Capital Management reduced its Abivax (ABVX) stake by 18% in Q3 2026, selling an estimated $4.82K and leaving 186 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Versant Capital Management first reported a position in ABVX in Q2 2026 and has held it in 2 quarters since. The position peaked at $30.1K in Q2 2026. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Versant Capital Management held 186 shares of Abivax worth $18.4K as of Q3 2026.
  • Versant Capital Management sold 40 Abivax shares in Q3 2026, an estimated $4.82K.
  • Abivax made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2006 holding.
  • Versant Capital Management first reported a position in Abivax in Q2 2026 and has held it in 2 quarters since.
  • Versant Capital Management's Abivax position peaked at $30.1K in Q2 2026.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.